Year | |||||||
2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | |
Total alive | 56 | 52 | 51 | 49 | 47 | 47 | 44 |
Antiepileptics | |||||||
N | 10 | 11 | 9 | 10 | 9 | 10 | 11 |
Median DDD | 213 | 159 | 194 | 145 | 131 | 113 | 46 |
Q1, Q3 | (46, 240) | (46, 293) | (93, 240) | (47, 240) | (91, 191) | (45, 240) | (28, 192) |
Benzodiazepines | |||||||
N | 29 | 26 | 26 | 22 | 21 | 22 | 21 |
Median DDD | 300 | 310 | 253 | 250 | 235 | 232 | 200 |
Q1, Q3 | (50, 617) | (78, 759) | (50, 829) | (75, 900) | (110, 1080) | (68, 900) | (100, 826) |
Antipsychotics | |||||||
N | 12 | 14 | 11 | 12 | 13 | 12 | 13 |
Median DDD | 134 | 163 | 168 | 117 | 133 | 125 | 131 |
Q1, Q3 | (34, 318) | (30, 307) | (70, 299) | (68, 270) | (70, 183) | (52, 302) | (54, 243) |
Hypnotics and sedatives | |||||||
N | 31 | 28 | 30 | 29 | 28 | 26 | 26 |
Median DDD | 400 | 419 | 389 | 400 | 369 | 406 | 382 |
Q1, Q3 | (200, 660) | (273, 838) | (190, 800) | (250, 700) | (165, 710) | (267, 1065) | (250, 752) |
Antidepressants | |||||||
N | 35 | 37 | 33 | 32 | 31 | 29 | 31 |
Median DDD | 739 | 658 | 750 | 575 | 600 | 550 | 600 |
Q1, Q3 | (450, 997) | (364, 990) | (444, 1092) | (384, 1003) | (364, 1012) | (400, 974) | (350, 911) |
Number of drugs above | |||||||
0 | 10 | 6 | 6 | 6 | 7 | 8 | 6 |
1 | 10 | 11 | 11 | 11 | 8 | 7 | 5 |
2 | 11 | 11 | 12 | 13 | 12 | 14 | 14 |
3 | 17 | 15 | 15 | 10 | 12 | 9 | 9 |
4 | 6 | 7 | 6 | 7 | 6 | 8 | 8 |
5 | 2 | 2 | 1 | 2 | 2 | 1 | 2 |
The number of patients on the specific class of drugs (N), and the median daily defined dose (DDD) and the 25th percentile (Q1) and 75th percentile (Q3) for those on that drug. A DDD of 365 implies that on average the patients are on standard dose daily during the whole year. A DDD of 730 implies double-standard dose daily. A DDD of 182 implies for example halved-standard dose daily or a shorter period on standard dose.